Yale Epidemiologist Harvey Risch: Lives Lost Due to Fauci/FDA Opposition to LIfe-saving Treatments

  • Post category:News

You may have heard the name Harvey Risch. If not, you will likely hear about him in the not too distant future. Some, particularly in the mainstream media, will likely try to smear him as a crackpot, or, at the least, as someone who is commenting on an area of science that is outside his area of expertise. Don’t believe any of this propaganda you are likely to hear. Believe instead those who point out that Dr. Risch is a science and public policy hero for coming forward to point out the failings of Dr. Anthony Fauci, the NIAD that Fauci leads, and the FDA that is the umbrella agency over the whole sordid mess.

HCQ Works. Banning Its Use Causes Needless Suffering and Death

  • Post category:News

For most of the spring and summer, after President Trump mentioned that he thought hydroxychloroquine might be effective at stopping COVID-19, the mainstream media and the medical and public health establishment engaged in a wholly unprecedented smear campaign designed to demonize the drug and take it away from doctors who might try to follow the science and treat COVID patients with it.

Yale Epidemiology Professor Touts Hydroxychloroquine Against COVID-19

  • Post category:News

“In the future, I believe this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence,” wrote Harvey Risch in a recent edition of Newsweek magazine.

The Science of Hydroxychloroquine

  • Post category:News

The Science of Hydroxychloroquine Written by  Dennis Behreandt It is one of the most commonly used drugs in the world. It has been available for decades and millions of people use…

The War on Hydroxychloroquine

  • Post category:News

As strange as it may sound, a propaganda and demonization campaign is being waged against hydroxychloroquine so that globalism and U.S. socialism can make headway.

Hydroxychloroquine Trial Restarts With UK Regulator Approval

  • Post category:News

A very large study of the potential role of hydroxychloroquine in preventing COVID-19 has restarted after a regulatory body in the UK re-approved the work. Known as the COPCOV study, it is being conducted by the MORU Tropical Health Network. MORU is an acronym for the Mahidol Oxford Tropical Medicine Research Unit, part of Mahidol University in Thailand.

FDA Backtracks on Hydroxychloroquine

  • Post category:News

The Food and Drug Administration has reversed course on its Emergency Use Authorization for hydroxychloroquine for the treatment of COVID-19. In a letter discussing the revocation of the EUA for the drug, FDA chief scientist Denise Hinton said the agency no longer found the drug likely to be effective in treating COVID-19.

Study Claiming Hydroxychloroquine Dangerous and Ineffective Is Retracted

  • Post category:News

 A study that was published to great fanfare in the prestigious journal The Lancet has now been retracted. The retracted study, titled “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” was led by Dr. Mandeep R. Mehra, a cardiologist and medical director of the Brighman and Women’s Hospital Heart and Vascular Center in Boston.

End of content

No more pages to load